Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Evaluation of Biomarkers of Exposure in Smokers Switching to a Carbon-Heated Tobacco Product: A Controlled, Randomized, Open-Label 5-Day Exposure Study.

Lüdicke F, Haziza C, Weitkunat R, Magnette J.

Nicotine Tob Res. 2016 Jul;18(7):1606-13. doi: 10.1093/ntr/ntw022.

2.

Prevalence and validity of self-reported smoking in Indigenous and non-Indigenous young adults in the Australian Northern Territory.

Pearce MS, Mann KD, Singh G, Davison B, Sayers SM.

BMC Public Health. 2014 Aug 21;14:861. doi: 10.1186/1471-2458-14-861.

3.

Nicotine reduction as an increase in the unit price of cigarettes: a behavioral economics approach.

Smith TT, Sved AF, Hatsukami DK, Donny EC.

Prev Med. 2014 Nov;68:23-8. doi: 10.1016/j.ypmed.2014.07.005.

4.

Reduced nicotine product standards for combustible tobacco: building an empirical basis for effective regulation.

Donny EC, Hatsukami DK, Benowitz NL, Sved AF, Tidey JW, Cassidy RN.

Prev Med. 2014 Nov;68:17-22. doi: 10.1016/j.ypmed.2014.06.020. Review.

5.

Investigation of complement component C4 copy number variation in human longevity.

Flachsbart F, Caliebe A, Heinsen FA, Hemming-Karlsen T, Schreiber S, Franke A, Nebel A.

PLoS One. 2014 Jan 22;9(1):e86188. doi: 10.1371/journal.pone.0086188.

6.

Adjustment for smoking does not alter the FOXO3A association with longevity.

Däumer C, Flachsbart F, Caliebe A, Schreiber S, Nebel A, Krawczak M.

Age (Dordr). 2014 Apr;36(2):911-21. doi: 10.1007/s11357-013-9578-z.

7.

The effect of menthol on cigarette smoking behaviors, biomarkers and subjective responses.

Strasser AA, Ashare RL, Kaufman M, Tang KZ, Mesaros AC, Blair IA.

Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):382-9. doi: 10.1158/1055-9965.EPI-12-1097.

8.

Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers.

Ashare RL, Tang KZ, Mesaros AC, Blair IA, Leone F, Strasser AA.

J Psychopharmacol. 2012 Oct;26(10):1383-90. doi: 10.1177/0269881112449397.

9.

Genetic toxicology and toxicogenomic analysis of three cigarette smoke condensates in vitro reveals few differences among full-flavor, blonde, and light products.

Yauk CL, Williams A, Buick JK, Chen G, Maertens RM, Halappanavar S, White PA.

Environ Mol Mutagen. 2012 May;53(4):281-96. doi: 10.1002/em.21689.

10.

Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes.

Benowitz NL, Dains KM, Hall SM, Stewart S, Wilson M, Dempsey D, Jacob P 3rd.

Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):761-9. doi: 10.1158/1055-9965.EPI-11-0644.

11.

A lack of association between severity of nicotine withdrawal and individual differences in compensatory nicotine self-administration in rats.

Harris AC, Pentel PR, Burroughs D, Staley MD, Lesage MG.

Psychopharmacology (Berl). 2011 Sep;217(2):153-66. doi: 10.1007/s00213-011-2273-9.

12.

Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.

Strasser AA, Benowitz NL, Pinto AG, Tang KZ, Hecht SS, Carmella SG, Tyndale RF, Lerman CE.

Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):234-8. doi: 10.1158/1055-9965.EPI-10-0674.

13.

Does switching to reduced ignition propensity cigarettes alter smoking behavior or exposure to tobacco smoke constituents?

O'Connor RJ, Rees VW, Norton KJ, Cummings KM, Connolly GN, Alpert HR, Sjödin A, Romanoff L, Li Z, June KM, Giovino GA.

Nicotine Tob Res. 2010 Oct;12(10):1011-8. doi: 10.1093/ntr/ntq139.

14.

Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention.

Hecht SS, Yuan JM, Hatsukami D.

Chem Res Toxicol. 2010 Jun 21;23(6):1001-8. doi: 10.1021/tx100056m.

15.

Behavioral filter vent blocking on the first cigarette of the day predicts which smokers of light cigarettes will increase smoke exposure from blocked vents.

Strasser AA, Tang KZ, Sanborn PM, Zhou JY, Kozlowski LT.

Exp Clin Psychopharmacol. 2009 Dec;17(6):405-12. doi: 10.1037/a0017649.

16.

Cigarette filter-based assays as proxies for toxicant exposure and smoking behavior--a literature review.

Pauly JL, O'Connor RJ, Paszkiewicz GM, Cummings KM, Djordjevic MV, Shields PG.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3321-33. doi: 10.1158/1055-9965.EPI-09-0925. Review.

17.

Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies.

Marian C, O'Connor RJ, Djordjevic MV, Rees VW, Hatsukami DK, Shields PG.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3305-20. doi: 10.1158/1055-9965.EPI-09-1014. Review.

18.

Clinical trials methods for evaluation of potential reduced exposure products.

Hatsukami DK, Hanson K, Briggs A, Parascandola M, Genkinger JM, O'Connor R, Shields PG.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3143-95. doi: 10.1158/1055-9965.EPI-09-0654. Review.

20.

Tobacco use among individuals with intellectual or developmental disabilities: a brief review.

Steinberg ML, Heimlich L, Williams JM.

Intellect Dev Disabil. 2009 Jun;47(3):197-207. doi: 10.1352/1934-9556-47.3.197. Review.

Items per page

Supplemental Content

Support Center